Go Back
Foresite Capital
Foresite Capital, a venture fund established in 2011, is based in San Francisco. Specializing in BioTech, Healthcare, Life Science, and more, they offer funding at various stages from Pre-Seed to Series D. The fund, led by Partner Matt Buten, has invested in companies like Kriya Therapeutics and Tasso among others. With 135 investments and 53 exits, Foresite Capital aims to support transformative healthcare ventures with catalytic capital. For more details, visit their website: www.foresitecapital.com.
About
About
About
Bio
Foresite Capital provides catalytic capital to transformative healthcare companies at all stages.
Location
San Francisco
Stage
Seed, Series A, Series B, Series C, Series D, Pre-Seed
Partner name
Matt Buten
Bio
Foresite Capital provides catalytic capital to transformative healthcare companies at all stages.
Location
San Francisco
Stage
Seed, Series A, Series B, Series C, Series D, Pre-Seed
Partner name
Matt Buten
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Life Science, Medical Device, Health & Wellness, Pharmaceuticals, Information Technology
Number of investments
135
Number of exits
53
Fund Type
Venture Fund
Portfolio Companies
Kriya Therapeutics, Remix Therapeutics, Genapsys, Tasso, TenSixteen Bio, Mythic Therapeutics, HealthVerity, Odyssey Therapeutics, Interline Therapeutics
Foresite Capital
Foresite Capital, a venture fund established in 2011, is based in San Francisco. Specializing in BioTech, Healthcare, Life Science, and more, they offer funding at various stages from Pre-Seed to Series D. The fund, led by Partner Matt Buten, has invested in companies like Kriya Therapeutics and Tasso among others. With 135 investments and 53 exits, Foresite Capital aims to support transformative healthcare ventures with catalytic capital. For more details, visit their website: www.foresitecapital.com.
About
Bio
Foresite Capital provides catalytic capital to transformative healthcare companies at all stages.
Location
San Francisco
Stage
Seed, Series A, Series B, Series C, Series D, Pre-Seed
Partner name
Matt Buten
Fund
Fund Focus
BioTech, Healthcare, Life Science, Medical Device, Health & Wellness, Pharmaceuticals, Information Technology
Number of investments
135
Number of exits
53
Fund Type
Venture Fund
Portfolio Companies
Kriya Therapeutics, Remix Therapeutics, Genapsys, Tasso, TenSixteen Bio, Mythic Therapeutics, HealthVerity, Odyssey Therapeutics, Interline Therapeutics